在胰岛素瘤细胞系Rin-5F中的yes相关蛋白1 (YAP1) 中的突变状态
1Department of Life Sciences, Faculty of Science, Okayama University of Science, Okayama, 700-0005, Japan.
Cancer genetics
|March 30, 2025
概括
YAP1基因突变可能预测免疫治疗反应. 研究人员在胰岛素瘤细胞中没有发现YAP1突变,这表明免疫检查点抑制剂对这些神经内分泌瘤的有效性降低,这需要进一步的临床试验.
科学领域:
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
- 免疫治疗是一种免疫疗法.
背景情况:
- 在各种癌症中,YAP1基因突变与对免疫检查点抑制剂 (ICI) 的增强反应有关.
- YAP1突变可能作为免疫疗法疗效的预测生物标志物.
- 胰岛素瘤中的YAP1基因状态,一种神经内分泌瘤,以前没有被记录.
研究的目的:
- 为了调查胰腺分泌胰岛素细胞系Rin-5F中YAP1基因突变的存在.
- 探索YAP1基因状态对胰岛素瘤免疫检查点抑制剂疗效的潜在影响.
主要方法:
- 从Rin-5F细胞中提取了基因组DNA和补充DNA.
- 使用已知的分子技术,分析了YAP1基因的突变.
主要成果:
- 在Rin-5F胰岛素瘤细胞系中,没有发现YAP1基因的突变.
- 这一发现与之前的报告形成鲜明对比,这些报告将YAP1突变与其他癌症的免疫治疗反应联系起来.
结论:
- 在这种胰岛素瘤细胞系中没有YAP1突变,这表明ICI可能对这些神经内分泌瘤的影响有限.
- 为了验证这些发现,需要进行进一步的临床试验,研究神经内分泌瘤 (包括胰岛素瘤) 的免疫检查点抑制剂.
相关概念视频
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
Insulin Secretory Vesicles
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
Insulin: The Receptor and Signaling Pathways
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...


